These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2167652)

  • 1. Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes.
    Palko MJ; Wang SE; Shackney SE; Cottington EM; Levitt SB; Hartsock RJ
    Arch Pathol Lab Med; 1990 Sep; 114(9):949-52. PubMed ID: 2167652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance.
    el-Naggar AK; Ro JY; McLemore D; Garnsy L
    Am J Clin Pathol; 1990 Apr; 93(4):480-5. PubMed ID: 2157332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological and clinical correlations of cystosarcoma phyllodes.
    Murad TM; Hines JR; Beal J; Bauer K
    Arch Pathol Lab Med; 1988 Jul; 112(7):752-6. PubMed ID: 2838007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystosarcoma phyllodes of the breast.
    Katsohis CD; Fahandides E; Agurigakis C; Aletras HA
    Int Surg; 1990; 75(3):162-5. PubMed ID: 2173680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations.
    Grimes MM
    Mod Pathol; 1992 May; 5(3):232-9. PubMed ID: 1323101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
    Berho M; Viciana AL; Poppiti RJ; Ruiz P
    J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystosarcoma phyllodes.
    Deodhar SD; Joshi S; Khubchandani S
    J Postgrad Med; 1989 Apr; 35(2):98-103. PubMed ID: 2559981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients.
    Keelan PA; Myers JL; Wold LE; Katzmann JA; Gibney DJ
    Hum Pathol; 1992 Sep; 23(9):1048-54. PubMed ID: 1325408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal neoplasms of the breast: a comparative flow cytometric study.
    El-Naggar AK; Mackay B; Sneige N; Batsakis JG
    J Surg Oncol; 1990 Jul; 44(3):151-6. PubMed ID: 2164618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystosarcoma phyllodes--a clinicopathologic analysis of 32 cases.
    Chowdhury C; Chattopadhyay TK; Pramanik M; Sarathy VV; Verma K
    Indian J Cancer; 1984; 21(1):23-30. PubMed ID: 6096262
    [No Abstract]   [Full Text] [Related]  

  • 15. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
    Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
    Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phyllodes tumors of the breast: correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome.
    Samaratunga H; Clarke B; Owen L; Bryson G; Swanson C
    Pathol Int; 2001 Nov; 51(11):866-73. PubMed ID: 11844053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
    Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
    Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma arising in cystosarcoma phyllodes: report of a case with a review of the literature.
    Ishida T; Izuo M; Kawai T
    Jpn J Clin Oncol; 1984 Mar; 14(1):99-106. PubMed ID: 6323792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
    Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
    Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.